Harwood Feffer LLP Announces Investigation of Lipocine Inc.
Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of
Lipocine Inc. (“Lipocine” or the “Company”) (NASDAQ: LPCN) concerning whether the board has breached its fiduciary duties to
shareholders.
Our investigation concerns whether the Lipocine board of directors has breached its fiduciary duties to shareholders, grossly
mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Lipocine shares and wish to discuss this matter with us, or have any questions concerning your rights and interests
with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers:
(877) 935-7400
(212) 935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous
cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future
matter.
Harwood Feffer LLP
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
(877) 935-7400
(212) 935-7400
bsachsmichaels@hfesq.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20180129006217/en/